FO-4-15, an anti-AD candidate with reduced neurotoxicity and enhanced neuroprotective effects
Sep. 20, 2024
Researchers from the Chinese Academy of Medical Sciences reported the discovery of the 1,2,4-oxadiazole derivative FO-4-15 for the treatment of Alzheimer’s disease (AD).
